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P01. GENDER FEATURES OF VERTEBRAL PAIN 
SYNDROME DEPENDING ON BONE MINERAL DENSITY
Vladyslav Povoroznyuk, Tetiana Orlyk
SI “D.F. Chebotarev Institute of Gerontology NAMS Ukraine”.
Objectives: The aim is to study the frequency of vertebral pain 
syndrome in men and women of older age groups depending on the 
bone mineral density (BMD).
Methods: We have examined 1,934 people aged 50-89 years, 
among them 1697 women and 237 men. The frequency of back pain 
syndrome was studied depending on BMD (osteoporosis, osteopenia, 
and norm). BMD at all sites was measured by DXA using a Prodigy 
densitometer (GE).
Results: The frequency of pain syndrome among older age 
groups is significantly higher in women compared with men (88.3% 
(1,499/1,697) vs 84.8% (201/237), accordingly, p = 0.01). In women 
of 50-89 years, with osteoporosis and no fractures in their anam-
nesis, pain syndrome in the thoracic and lumbar spine is signifi-
cantly higher in comparison with women who have osteopenia 
(p = 0.01) and normal BMD (p = 0.02) and compared to men with a 
similar BMD state (osteoporosis; (91.8% (337/367) vs 76.2% (16/21), 
accordingly, p = 0.01)). The frequency of pain syndrome in the tho-
racic and the lumbar spine in women is associated with BMD. The 
presence of osteoporosis increases the risk of pain syndrome in the 
thoracic spine (RR = 1.27, 95%CI: 1.12-1.44, p = 0.0001). In older 
women, the presence of low-energy fractures significantly impacts 
the increasing frequency of pain in the thoracic region regardless 
of the BMD state.
Conclusions: The frequency of pain among older age groups is 
significantly higher in women compared with men. In women of 
older age groups, the presence of low-energy fractures significantly 
increases the frequency of pain in the thoracic region, regardless of 
the state of BMD. In women 50-89 years old, with osteoporosis and 
no low-energy fractures, the frequency of pain in the thoracic and 
lumbar regions is significantly higher compared to women with os-
teopenia and normal BMD, as well as compared to men with a similar 
BMD state (osteoporosis).
P02. BETA-2 ADRENERGIC RECEPTOR (ADRB2) 
GENE POLYMORPHISMS AS RISK FACTORS FOR REDUCED 
BONE MINERAL DENSITY
Raquel Simões1,2, Joana Ferreira1,2, Ana Paula Barbosa2,3,4, 
Mário Rui Mascarenhas2,3,4, Manuel Bicho1,2
1Institute for Scientific Research Bento Rocha Cabral. 2ISAMB, 
Genetics Laboratory, Lisbon Medical School. 3Clinic of Endocrinology, 
Diabetes and Metabolism, Lda. 4Department of Endocrinology, 
Diabetes and Metabolism, Santa Maria Hospital.
Introduction: Beta-2-adrenergic receptor (ADRB2) has been 
identified in osteoblasts and osteoclasts. It is known that it is in-
volved in the inhibition of bone formation by osteoblasts and promo-
tion of osteoclastogenesis by increasing RANKL. The gene encoding 
this receptor is polymorphic and such mutations, namely Arg16Gly 
and Gln27Glu polymorphisms, can cause a down-regulation of intra-
cellular trafficking of the receptor that leads to an increase in desen-
sitization of the related reaction.
Objectives: To study the association between Beta-2 Adrenergic 
Receptor (ADRB2) gene polymorphisms Arg16Gly and Gln27Glu and 
osteoporosis.
Methods: Bone mineral density (BMD_g/cm2) was measured by 
DEXA in 93 females: 61 with normal BMD (age = 44.9 ± 11.9 years; 
BMI = 30.6 ± 5.9 kg/m2) and 31 with reduced bone mass/osteopenia 
and osteoporosis (age = 62.3 ± 13.3 years; BMI = 25.2 ± 3.9 kg/m2). 
Bone remodeling parameters were analyzed by standard methods: 
alkaline phosphatase, alkaline phosphatase bone fraction and os-
teocalcin. Beta-2 Adrenergic Receptor (ADRB2) gene polymor-
phisms Arg16Gly and Gln27Glu were studied by PCR-RFLP and 
dominant and recessive models were applied to stablish genotype 
groups. Statistical analysis by SPSS 21.0 and statistical significance 
for p < 0.05.
Results: Age and BMI are different between normal and reduced 
BMD (p < 0.001) but didn’t differ between Arg16Gly or Gln27Glu ge-
notypes. We found significant differences between ADRB2_Arg-
16Gly polymorphism and BMD with a higher frequency of AA 
genotype in females with reduced BMD (p = 0.019). These ones 
showed higher risk for reduced bone mass (OR = 3.470, 95%CI 1.225-
9.833). Regarding ADRB2_ Gln27Glu polymorphism, we found a ten-
dency for a higher frequency of CC genotype in females with reduced 
BMD (p = 0.058). We didn’t find significant differences between 
ADRB2_Arg16Gly and ADRB2_ Gln27Glu polymorphisms and bone 
remodeling parameters, neither in the general population nor in 
those with normal or reduced BMD.
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Conclusions: Arg16Gly and Gln27Glu polymorphisms in the gene 
encoding Beta-2 Adrenergic Receptor (ADRB2) may be risk factors for 
reduced bone mineral density in females.
P03 -IDENTIFICATION OF NEUROPATHIC PAIN 
COMPONENT IN PATIENTS OF VARIOUS AGE WITH KNEE 
OSTEOARTHRITIS
V.V. Povoroznyuk, U.I. Pryimych
D.F. Chebotarev Institute of Gerontology NAMS Ukraine, Kyiv, 
Ukraine.
Introduction: Osteoarthritis-induced pain is a result of nocicep-
tor stimulation, associated with local tissue damage and inflamma-
tion. Resent data suggest the presence of neuropathic pain symptoms 
in patients with osteoarthritis.
Objectives: The aim of this study was to estimate the structure of 
pain syndrome, reveal the presence of neuropathic pain (NP) compo-
nent, symptoms and signs of NP in patients suffering from knee os-
teoarthritis.
Methods: We’ve examined 44 patients with knee osteoarthritis 
of the II-III stages by the Kallgren-Lawrence scale aged 47-85 years 
(average age 66.1 ± 1.5 years). To assess the NP component, we used 
screening scales painDETECT, LANSS, DN4 questionnaires. To assess 
intensity of pain, visual analogue scale (VAS) was used. Besides 
 WOMAC and EuroQol-5D questionnaire were applied. For statistical 
analysis of results, ANOVA, correlation and regression analysis was 
applied.
Results: 4.6% of patients with knee osteoarthritis examined by 
painDETECT were likely to have the NP component. LANSS scale: 25% 
were probably to have NP. DN4 scale: 31.2% probably had NP. Moder-
ate to significant correlations were found between intensity of pain 
by VAS data and Neuropathic Pain Scales (painDETECT, LANSS, DN4) 
data (p < 0.05). It was established that higher results of screening by 
painDETECT and DN4 positively correlate with a disturbance of 
physical function tested by WOMAC (p < 0.05). PainDETECT data 
have moderate to significant correlations with EuroQol-5D question-
naire (p < 0.01). Verbal descriptors as pins and needles, tingling, 
numbness and allodynia, pain from light touch which are revealed 
by 3 screening scales can significantly contribute to the likely neu-
ropathic component in patients with knee osteoarthritis (p < 0.05). 
Burning pain (p < 0.01), pins and needles (p < 0.05) can be associated 
with a more severe pain in patients with knee osteoarthritis.
Conclusions: Thus, in patients with osteoarthritis the pain syn-
drome may reveal NP features. Identification of these would promote 
a targeted treatment strategy.
P04. EVALUATION OF BONE MINERAL DENSITY 
IN ADOLESCENTES WITH ANOREXIA NERVOSA
Patrícia Gouveia, Ricardo Teixeira, Rui Brito, Rosa Castro, 
Inês Amorim
Medicina Nuclear.
Introduction: One of Anorexia Nervosa’s (AN) most frequent 
complications is the loss of bone mass, which represents a serious 
problem in adolescence, as it may reduce the peak bone mass at-
tained, leading to osteopenia and osteoporosis.
Objectives: The objective of our study was to evaluate the preva-
lence of the reduction of Bone Mineral Density (BMD) in adolescents 
with AN, and its relation to anthropometric data (weight, height and 
BMI).
Methods: 66 adolescents with AN, referred to the Santo António 
Hospital Nuclear Medicine service between 2008 and 2015, were 
retrospectively studied. A Hologic QDR-4500 densitometer was used 
to calculate BMD, Z-score and BMC. The correlation between vari-
ables was determined by linear regression analysis. The significance 
level was established at p ≤ 0,05.
Results: The studied population presented average values of 0.86 
± 0.11 g/cm2 of BMD, -0.67 ± 1.21 of Z-score and 26.82 ± 15.05 g of 
BMC. 14% of patients presented with bone mineralisation values be-
low the variation expected for the age (Z-score < -2), it being that 40% 
of patients had a reduction of bone mass, defined, in this study, by a 
Z-score < -1. Further, there was a significant correlation between the 
anthropometric data and bone mineral density, more notorious in 
relation to weight and to BMC.
Conclusions: The results showed that, in an adolescent popula-
tion with AN, more than half of the individuals show no significant 
changes in BMD. These results are similar to those of previous stud-
ies and demonstrate that, in the disease’s initial stages, BMD is rela-
tively maintained. This study stresses the importance of early 
diagnosis of AN in adolescents, so as to find strategies to prevent loss 
of bone mass in this age group and impede the reduction in peak 
bone mass expected, which could leave to future severe complica-
tions.
P05. OSTEOPOROSIS IN NEUROLOGICAL DISORDERS
Vladyslav Povoroznyuk, Maryna Bystrytska, Iryna Karaban, 
Nina Karasevych
Institute of Gerontology NAMS Ukraine, Kyiv, Ukraine.
Introduction: Neurological disorders, notably stroke, Parkinson’s 
disease and spinal cord injury are associated with increased falls risk 
and fracture risk.
Objectives: The aim of the research is to define the bone mineral 
density in patients, with neurological disorders.
Methods: We examined 48 men and women with Parkinson’s 
disease (duration of Parkinson’s disease was at list 5 years and all 
were on L-dopa treatment), 52 stroke patients (men and women), 
21 patients with chronic spinal cord injury (AIS score A, B) and 
healthy people of appropriate age.
Results: BMD of patients with Parkinson’s disease was signifi-
cantly lower compared with BMD of healthy persons, both men and 
women (BMD lumbar spine women = 1.00 ± 0.15 vs 1.11 ± 0.15 g/cm2, 
p < 0.05, the difference of BMD was about 15%, and BMD lumbar 
spine men = 1.16 ± 0.24 vs 1.29 ± 0.24 g/cm2, p < 0.05). BMD stroke 
patients was also significantly lower compared with BMD of healthy 
persons: (BMD lumbar spine = 1.13 ± 0.20 vs 1.28 ± 0.46 g/cm2, 
p < 0.05, BMD total hip = 0.97 ± 0.18 vs 1.09 ± 0.25 g/cm2, p < 0.05). In 
women the difference was significant at the level of the total body 
and distal forearm. In men, the difference was significant only in the 
group of the patients with moderate and severe paresis. BMD SCI 
patients was dramatically low (BMD lumbar spine = 1.14 ± 0.19 vs 
1.24 ± 0.26 g/cm2, p < 0.05, BMD total hip = 0.82 ± 0.28 vs 1.07 ± 
0.27 g/cm2, p < 0.05), the difference of BMD was about 23%.
Conclusions: BMD in men and women with neurological disor-
ders (Parkinson’s disease, stroke and spinal cord injury) was signifi-
cantly lower than in healthy persons of the same age.
P06. EVIDENCE OF ISOFLAVONES USE IN OSTEOPOROSIS 
PREVENTION
Ângela Lee Chin, Ana Filipa Vicente, Olena Berezovska Lourenço
Medicina Geral e Familiar.
Osteoporosis is characterized by decreased bone mass and mi-
croarchitectural deterioration of bone, increasing fracture risk. 
